135 related articles for article (PubMed ID: 9144392)
1. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
Kim SY; Park WM; Jung SW; Lee J
Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
[TBL] [Abstract][Full Text] [Related]
2. Identification of preferred substrate sequences for transglutaminase 1--development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin.
Sugimura Y; Hosono M; Kitamura M; Tsuda T; Yamanishi K; Maki M; Hitomi K
FEBS J; 2008 Nov; 275(22):5667-77. PubMed ID: 18959752
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminases in skin epidermis.
Hitomi K
Eur J Dermatol; 2005; 15(5):313-9. PubMed ID: 16172037
[TBL] [Abstract][Full Text] [Related]
4. Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles.
Yamane A; Fukui M; Sugimura Y; Itoh M; Alea MP; Thomas V; El Alaoui S; Akiyama M; Hitomi K
FEBS J; 2010 Sep; 277(17):3564-74. PubMed ID: 20716179
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase crosslinking and structural studies of the human small proline rich 3 protein.
Steinert PM; Candi E; Tarcsa E; Marekov LN; Sette M; Paci M; Ciani B; Guerrieri P; Melino G
Cell Death Differ; 1999 Sep; 6(9):916-30. PubMed ID: 10510474
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation.
Egberts F; Heinrich M; Jensen JM; Winoto-Morbach S; Pfeiffer S; Wickel M; Schunck M; Steude J; Saftig P; Proksch E; Schütze S
J Cell Sci; 2004 May; 117(Pt 11):2295-307. PubMed ID: 15126630
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin.
Harrison CA; Layton CM; Hau Z; Bullock AJ; Johnson TS; MacNeil S
Br J Dermatol; 2007 Feb; 156(2):247-57. PubMed ID: 17223863
[TBL] [Abstract][Full Text] [Related]
8. Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1.
Kim SY; Bae CD
Exp Mol Med; 1998 Dec; 30(4):257-62. PubMed ID: 9894158
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: in vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1.
Oji V; Oji ME; Adamini N; Walker T; Aufenvenne K; Raghunath M; Traupe H
Br J Dermatol; 2006 May; 154(5):860-7. PubMed ID: 16634887
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte transglutaminase: differentiation marker and member of an extended family.
Rice RH; Mehrpouyan M; O'Callahan W; Parenteau NL; Rubin AL
Epithelial Cell Biol; 1992 Jul; 1(3):128-37. PubMed ID: 1364041
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
Case A; Stein RL
Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase cross-linking properties of the small proline-rich 1 family of cornified cell envelope proteins. Integration with loricrin.
Candi E; Tarcsa E; Idler WW; Kartasova T; Marekov LN; Steinert PM
J Biol Chem; 1999 Mar; 274(11):7226-37. PubMed ID: 10066784
[TBL] [Abstract][Full Text] [Related]
13. Analysis on transglutaminase 1 and its substrates using specific substrate peptide in cultured keratinocytes.
Yamane M; Sugimura K; Kawasaki H; Tatsukawa H; Hitomi K
Biochem Biophys Res Commun; 2016 Sep; 478(1):343-348. PubMed ID: 27416753
[TBL] [Abstract][Full Text] [Related]
14. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies.
Hitomi K; Presland RB; Nakayama T; Fleckman P; Dale BA; Maki M
J Dermatol Sci; 2003 Aug; 32(2):95-103. PubMed ID: 12850301
[TBL] [Abstract][Full Text] [Related]
15. Development of a mechanism-based assay for tissue transglutaminase--results of a high-throughput screen and discovery of inhibitors.
Case A; Ni J; Yeh LA; Stein RL
Anal Biochem; 2005 Mar; 338(2):237-44. PubMed ID: 15745743
[TBL] [Abstract][Full Text] [Related]
16. Facilitated wound healing by activation of the Transglutaminase 1 gene.
Inada R; Matsuki M; Yamada K; Morishima Y; Shen SC; Kuramoto N; Yasuno H; Takahashi K; Miyachi Y; Yamanishi K
Am J Pathol; 2000 Dec; 157(6):1875-82. PubMed ID: 11106560
[TBL] [Abstract][Full Text] [Related]
17. The human papillomavirus type 11 E1--E4 protein is a transglutaminase 3 substrate and induces abnormalities of the cornified cell envelope.
Brown DR; Kitchin D; Qadadri B; Neptune N; Batteiger T; Ermel A
Virology; 2006 Feb; 345(1):290-8. PubMed ID: 16257432
[TBL] [Abstract][Full Text] [Related]
18. Chronic ultraviolet radiation modulates epidermal differentiation as it up-regulates transglutaminase 1 and its substrates.
Lee DS; Quan G; Choi JY; Kim SY; Lee SC
Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):45-52. PubMed ID: 15634223
[TBL] [Abstract][Full Text] [Related]
19. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
Fontana A; Spolaore B; Mero A; Veronese FM
Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
[TBL] [Abstract][Full Text] [Related]
20. Inactive zymogen and highly active proteolytically processed membrane-bound forms of the transglutaminase 1 enzyme in human epidermal keratinocytes.
Steinert PM; Chung SI; Kim SY
Biochem Biophys Res Commun; 1996 Apr; 221(1):101-6. PubMed ID: 8660317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
